TABLE OF CONTENTS
Volume 14, Issue 1 (January 2007)
Review
Antisense and nonantisense effects of antisense Bcl-2 on multiple roles of Bcl-2 as a chemosensitizer in cancer therapy
R Kim, M Emi, K Matsuura and K Tanabe
Cancer Gene Ther 14: 1-11; advance online publication, October 13, 2006; doi:10.1038/sj.cgt.7700986
Original Articles
Enhancement of adenoviral MDA-7-mediated cell killing in human lung cancer cells by geldanamycin and its 17-allyl- amino-17-demethoxy analogue
A Pataer, D Bocangel, S Chada, J A Roth, K K Hunt and S G Swisher
Cancer Gene Ther 14: 12-18; advance online publication, October 6, 2006; doi:10.1038/sj.cgt.7700989
Replication-deficient rSV40 mediate pancreatic gene transfer and long-term inhibition of tumor growth
P Cordelier, C Bienvenu, H Lulka, F Marrache, M Bouisson, A Openheim, D S Strayer, N Vaysse, L Pradayrol and L Buscail
Cancer Gene Ther 14: 19-29; advance online publication, September 22, 2006; doi:10.1038/sj.cgt.7700987
Enriching suicide gene bearing tumor cells for an increased bystander effect
M M Unger, J Wahl, A Ushmorov, B Buechele, T Simmet, K-M Debatin and C Beltinger
Cancer Gene Ther 14: 30-38; advance online publication, October 6, 2006; doi:10.1038/sj.cgt.7700995
Suppression of tumor growth by intra-muscular transfer of naked DNA encoding adrenomedullin antagonist
T Miseki, H Kawakami, M Natsuizaka, S Darmanin, H Y Cui, J Chen, Q Fu, F Okada, M Shindo, F Higashino, M Asaka, J Hamuro and M Kobayashi
Cancer Gene Ther 14: 39-44; advance online publication, July 14, 2006; doi:10.1038/sj.cgt.7700979
Engineered herpes simplex virus expressing bacterial cytosine deaminase for experimental therapy of brain tumors
M B Guffey, J N Parker, W S Luckett Jr, G Y Gillespie, S Meleth, R J Whitley and J M Markert
Cancer Gene Ther 14: 45-56; advance online publication, September 22, 2006; doi:10.1038/sj.cgt.7700978
Sensitivity of 5-fluorouracil-resistant cancer cells to adenovirus suicide gene therapy
C Richard, W Duivenvoorden, D Bourbeau, B Massie, W Roa, J Yau and J Th'ng
Cancer Gene Ther 14: 57-65; advance online publication, July 28, 2006; doi:10.1038/sj.cgt.7700980
Inhibition of hepatocarcinoma by systemic delivery of Apoptin gene via the hepatic asialoglycoprotein receptor
D-J Peng, J Sun, Y-Z Wang, J Tian, Y-H Zhang, M H M Noteborn and S Qu
Cancer Gene Ther 14: 66-73; advance online publication, July 28, 2006; doi:10.1038/sj.cgt.7700985
Gene therapy of liver tumors with human liver-specific nanoparticles
Y Iwasaki, M Ueda, T Yamada, A Kondo, M Seno, K Tanizawa, S Kuroda, M Sakamoto and M Kitajima
Cancer Gene Ther 14: 74-81; advance online publication, September 22, 2006; doi:10.1038/sj.cgt.7700990
Potent antitumor efficacy of XAF1 delivered by conditionally replicative adenovirus vector via caspase-independent apoptosis
R Qi, J Gu, Z Zhang, K Yang, B Li, J Fan, C Wang, Z He, L Qiao, Z Lin and X Y Liu
Cancer Gene Ther 14: 82-90; advance online publication, September 29, 2006; doi:10.1038/sj.cgt.7700992
Conversion of a tumor-binding peptide identified by phage display to a functional chimeric T cell antigen receptor
C R J Pameijer, A Navanjo, B Meechoovet, J R Wagner, B Aguilar, C L Wright, W-C Chang, C E Brown and M C Jensen
Cancer Gene Ther 14: 91-97; advance online publication, October 6, 2006; doi:10.1038/sj.cgt.7700993
Persistent mismatch repair deficiency following targeted correction of hMLH1
M B Weiss, M I Vitolo, K Baerenfaller, G Marra, B H Park and K E Bachman
Cancer Gene Ther 14: 98-104; advance online publication, November 3, 2006; doi:10.1038/sj.cgt.7700997
Vascular endothelial growth factor promoter-based conditionally replicative adenoviruses for pan-carcinoma application
K Takayama, P N Reynolds, Y Adachi, L Kaliberova, J Uchino, Y Nakanishi and D T Curiel
Cancer Gene Ther 14: 105-116; advance online publication, October 6, 2006; doi:10.1038/sj.cgt.7700991
